Davis Polk & Wardwell LLP
Jason Kyrwood
Partner
+1 212 450 4653
Mr. Kyrwood is co-head of Davis Polk’s Finance Group. He regularly advises
financial institutions and alternative credit providers on a full range of financial
products, from large-cap syndicated loans to smaller direct lending
transactions. Advising on over half a trillion dollars of transactions since 2015,
Mr. Kyrwood has broad exposure to the global banking market and its industry
participants, including deep experience in leveraged and investment-grade
acquisition financings, bridge financings, LBOs, cross-border financings,
restructurings and recapitalizations.
Mr. Kyrwood has represented lenders in connection with some of the largest and
most complex investment grade acquisition financings over the last few years,
including the over $38 billion financing for AbbVie’s acquisition of Abbott, $33.5
billion financing for Bristol Myers Squibb’s acquisition of Celgene and Cigna’s
$26.7 billion financing for its acquisition of Express Scripts, among many others.
He also represented Comcast in its £22 billion financing for its acquisition of Sky.
He also represents financial institutions in LBO financings across from some of
the world’s largest and most sophisticated financial sponsors. Recent transaction
include the $8.05 billion financing for KKR’s acquisition of Envision Health Care,
$4.025 billion financing of Brand Energy & Infrastructure Services’ (a CD&R
portfolio company) acquisition of Safway Group, the $4.5 billion financing for CC
Capital’s acquisition of the Dun & Bradstreet Corporation and the $3.35 billion
financing for Brookfield’s acquisition of Genesee & Wyoming. He also represents
lenders in leveraged corporate transactions, including the $4.15 billion financing
for the acquisition by United Natural Foods of Supervalu, Inc.
Mr. Kyrwood is recognized in Chambers Global and Chambers USA as a leading
lawyer, and has received numerous honors, including being named
“Transatlantic Dealmaker of the Year” (2016) and “Dealmaker of the Year” (2014,
2020) by The American Lawyer, “Rising Star" by New York Law Journal (2015)
and Law360 (2011), and one of The M&A Advisor’s “40 Under 40” (2012). He is
also a regular speaker and author on leveraged finance matters.
Work Highlights
Notable Large-Cap Leveraged Financings
$34.35 billion exit financing for PG&E Corporation
$5.79 billion financing for Bausch Health (formerly Valeant Pharmaceuticals)
$4.58 billion financing for CC Capital's acquisition of The Dun & Bradstreet
Corporation
$4.15 billion financing for United Natural Foods' acquisition of Supervalu